NeRRe

NeRRe nabs £20M to test chronic cough drug in patients with a fatal lung disease
MedCity News
Thu, 07/8/21 - 10:54 am
NeRRe
clinical trial
idiopathic pulmonary fibrosis
clinical trials
After selling its spinout to Bayer in a $875M-plus deal, NeRRe Therapeutics grabs $28M for some 'unfinished business'
Endpoints
Wed, 07/7/21 - 10:58 am
NeRRe
Bayer
M&A
Mary Kerr
KaNDy Therapeutics
NeRRe hopes to advance cough candidate despite Phase II miss
BioCentury
Fri, 06/7/19 - 09:57 pm
NeRRe
orvepitant
clinical trials
chronic cough